Hong Yang

This inventor holds 48 USPTO granted patents and 18 published patent applications, plus 2 CIPO patents and 20 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Gilead Sciences, Inc., Abbvie Inc., Novartis Vaccines & Diagnostics, Gmbh. Active years: 2009-2025.

USPTO Granted Patents = 48 (Patent Applications = 18)

% Patents Active = 91.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 20 (Patent Applications = 21)

Average Co-Inventor Count = 9.9

ph-index = 12

Forward Citations = 414(Granted Patents)

Location History:

Foster City, CA (US) (2009)
Pleasant Hill, CA (US) (2009 - 2012)
Worchester, MA (US) (2015)
Worcester, MA (US) (2015 - 2018)
Fremont, CA (US) (2010 - 2024)

Company Filing History:

33 out of 946

Gilead Sciences, Inc.

Novartis Vaccines & Diagnostics, Gmbh

Years Active: 2009-2025

Loading Chart...

Areas of Expertise:

MCL1 Inhibitors

HIV Protease Inhibitors

Toll-Like Receptor Modulators

Bridged Tricyclic Carbamoylpyridone

Substituted Pyridotriazine

Protein Purification

Low Acidic Species

Benzothiazole Compounds

Therapeutic Compounds

Naphthalene Acetic Acid Derivatives

Pharmaceutical Use

Methods of Preparation

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421235 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2025-09-23),

2. 12227520 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2025-02-18),

3. 12202842 - MCL1 inhibitors (2025-01-21),

4. 12187734 - Substituted pyridotriazine compounds and uses thereof (2025-01-07),

5. 12162844 - MCL-1 inhibitors (2024-12-10),

6. 12054496 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2024-08-06),

7. 12024528 - Bridged tricyclic carbamoylpyridone compounds and uses thereof (2024-07-02),

8. 11897892 - Substituted pyridotriazine compounds and uses thereof (2024-02-13),

9. 11667652 - MCL1 inhibitors (2023-06-06),

10. 11643400 - MCL-1 inhibitors (2023-05-09),

11. 11613546 - Substituted pyridotriazine compounds and uses thereof (2023-03-28),

12. 11548902 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2023-01-10),

13. 11352329 - HIV protease inhibitors (2022-06-07),

14. 11110091 - Modulators of toll-like receptors (2021-09-07),

15. 11084832 - Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use (2021-08-10),

Title: Unveiling the Innovations of Inventor Hong Yang from Fremont, CA

Introduction: Meet Hong Yang, a prolific inventor hailing from Fremont, CA, whose groundbreaking work has resulted in 32 patents in various fields of cutting-edge science and technology.

Latest Patents: Among his recent patents are the 'Substituted pyridotriazine compounds and uses thereof' which focus on combating HIV infections, and 'MCL1 inhibitors' dedicated to developing treatments for cancer.

Career Highlights: Hong Yang has contributed his expertise to renowned companies such as Gilead Sciences, Inc. and Novartis Vaccines & Diagnostics, Gmbh, where his innovative spirit and dedication have shone through in his numerous patent applications.

Collaborations: Throughout his career, Hong Yang has collaborated with esteemed professionals in the field, including coworkers like Ryan McFadden and Paul A Roethle, fostering a culture of innovation and excellence.

Conclusion: In conclusion, Hong Yang stands as a beacon of ingenuity in the realm of inventions, with his patents reflecting a commitment to pushing the boundaries of scientific exploration and improving human health.